Teva Pharmaceutical Industries annual shares outstanding
2008
2009
2010
Teva Pharmaceutical Industries Shares Outstanding History (TEVA)
Teva Pharmaceutical Industries reported 937.0M shares outstanding at the end of fiscal 2010.
View full Teva Pharmaceutical Industries company overviewTeva Pharmaceutical Industries annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2010 | 2010-12-31 | 937.0M | 14.0M | +1.52% |
| 2009 | 2009-12-31 | 923.0M | 34.0M | +3.82% |
| 2008 | 2008-12-31 | 889.0M | — | — |
Teva Pharmaceutical Industries quarterly shares outstanding
Q4.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2011 | 2011-06-30 | 940.0M | 5.0M | +0.53% |
| Q1 2011 | 2011-03-31 | 940.0M | 17.0M | +1.84% |
| Q4 2010 | 2010-12-31 | 937.0M | 14.0M | +1.52% |
| Q3 2010 | 2010-09-30 | 936.0M | 17.0M | +1.85% |
| Q2 2010 | 2010-06-30 | 935.0M | 23.0M | +2.52% |
| Q1 2010 | 2010-03-31 | 923.0M | 32.0M | +3.59% |
| Q4 2009 | 2009-12-31 | 923.0M | 34.0M | +3.82% |
| Q3 2009 | 2009-09-30 | 919.0M | — | — |
| Q2 2009 | 2009-06-30 | 912.0M | — | — |
| Q1 2009 | 2009-03-31 | 891.0M | — | — |
| Q4 2008 | 2008-12-31 | 889.0M | — | — |
Teva Pharmaceutical Industries shares outstanding trends
Across the available reported history, Teva Pharmaceutical Industries's shares outstanding moved from 923.0M to 937.0M, a change of 14.0M. The latest reported quarter, Q2 2011, shows 940.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teva Pharmaceutical Industries filings at SEC.gov ↗